Shareholder Alert: Robbins LLP Announces That Decision Diagnostics Corp. (DECN) is Being Sued for Misleading Shareholders
SAN DIEGO & WESTLAKE, Calif.–(BUSINESS WIRE)–Shareholder rights law firm Robbins LLP announces that a purchaser of Decision Diagnostics Corp. (OTC: DECN) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between March 3, 2020 and December 17, 2020. Decision Diagnostics offers prescription and non-prescription diagnostics and homes testing products.
If you suffered a loss due to Decision Diagnostics Corp.’s misconduct, click here.
Decision Diagnostics Corp. (DECN) Misled Shareholders Regarding the Availability of its Blood Test to Detect COVID-19
According to the complaint, throughout the relevant period, defendants claimed that…